Although the binding of RP02 antibody to CD38 is weaker than that of 028 antibody, when activated by CD38‐positive tumor cell lines, RP02 CAR‐T cells consistently produced a stronger cytokine response than 028 CAR‐T cells. The gene discussed is CD38; the disease is neoplasm.